Your search for bevacizumab returned 7 results

Active Filters

Click on a filter below to refine your search. Remove a filter to broaden your search.

Brian Park, PharmD remove

Your search for bevacizumab returned 7 results

Sort Results:

Relevant Recent
News

Keytruda Approved as First-Line Treatment of MSI-H or dMMR Colorectal Cancer

The FDA has approved Keytruda (pembrolizumab; Merck), a programmed death receptor-1 -blocking antibody, as monotherapy for the first-line treatment of patients with unresectable or metastatic microsatellite instability-high (MSI-H) or mismatch repair deficient (dMMR) colorectal cancer.
Generics News

Pfizer Announces Launch of Three Biosimilar Cancer Treatments

Pfizer announced the launch of 3 new biosimilars: Zirabev (bevacizumab-bvzr), Ruxience (rituximab-pvvr) and Trazimera (trastuzumab-qyyp).  Zirabev, a biosimilar to Avastin (bevacizumab; Genentech), is available for the treatment of 5 types of cancer: metastatic colorectal cancer; unresectable, locally advanced, recurrent or metastatic non-squamous non-small cell lung cancer; recurrent glioblastoma; metastatic renal cell carcinoma; and persistent, recurrent…